enVVeno Medical Corp (NVNO) — Strategic Asset Allocation Index

Latest as of December 2022: 1.3%

enVVeno Medical Corp (NVNO) has a Strategic Asset Allocation Index of 1.3% as of December 2022. Strategic assets (PP&E of $521.00K plus long-term investments of $-) total $521.00K, measured against net assets of $38.73 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check enVVeno Medical Corp (NVNO) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

SAAI

1.3%
Strategic Assets / Net Assets

Strategic Assets

$521.00K
PP&E + LT Investments

PP&E

$521.00K
USD

Net Assets

$38.73 Million
USD

enVVeno Medical Corp Strategic Asset Allocation Index (2018–2022)

This chart shows how enVVeno Medical Corp's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of December 2022, the index stands at 1.3%, representing strategic assets of $521.00K against net assets of $38.73 Million USD. See financial flexibility index of enVVeno Medical Corp to measure the company's free cash flow as a share of total liabilities.

Annual Strategic Asset Allocation Index for enVVeno Medical Corp (2018–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for enVVeno Medical Corp from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of enVVeno Medical Corp.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2022 1.3% $521.00K $521.00K $- $38.73 Million ▼ -3.4 pp
2021 4.8% $2.60 Million $2.60 Million $- $54.40 Million ▼ -8.4 pp
2020 13.2% $938.94K $938.94K $- $7.10 Million ▼ -105.0 pp
2019 118.2% $1.17 Million $1.17 Million $- $989.94K ▲ +116.9 pp
2018 1.3% $26.15K $26.15K $- $2.04 Million
pp = percentage points